Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1025852C details a novel route for quinolone intermediates. Discover cost-effective synthesis and scalable manufacturing solutions for complex diazabicyclic compounds.
Advanced preparation method for Omarigliptin chiral intermediates via novel aldol condensation and RCM. Offers cost reduction and scalable supply for global pharmaceutical manufacturing.
Patent CN106866657A reveals T3P-mediated synthesis boosting Ergometrine yield to 92.6%. Discover cost-effective manufacturing and high-purity supply chain solutions.
Novel L-serine based route for Marizomib intermediates. High yield, green solvents, scalable process for API manufacturing.
Novel side-chain first coupling strategy for Somaglutide reduces racemization and enhances yield for industrial scale-up.
Patent CN108947919B reveals a safer route avoiding thiophosgene, offering cost reduction in pharmaceutical manufacturing and enhanced supply reliability.
Advanced patent CN102702114B enables safer nitroorotic acid production. Reduced explosion risks and high purity for reliable pharmaceutical intermediates supply chains.
Novel solvent system enables direct filtration for LCZ696. Reduces impurities significantly. Ideal for pharmaceutical supply chains.
Patent CN102060720A details a superior Pd/C catalyzed route for beta-tricyclic amine hydrochloride, offering enhanced purity and cost reduction in API manufacturing.
Discover the novel geminal dichlorination route for Pitavastatin intermediates. High purity, scalable manufacturing, and significant cost reduction for global supply chains.
Novel enzymatic route for posaconazole intermediate improves yield and purity. Cost-effective manufacturing solution for antifungal API supply chains.
Patent CN115215765A reveals a high-yield method for Crisaborole Polymer Impurity A. Discover cost-effective synthesis routes for pharmaceutical quality control standards.
Novel single-atom Fe catalysis for 2-amidoquinoline. Green, efficient route for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN103772479A enables eco-friendly sulfonation using crude extracts. Reduces costs and environmental impact for cardiovascular drug manufacturing supply chains.
Patent CN115872894B reveals a safer copper-catalyzed route for contrast agent intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104356022B reveals high-yield synthesis for pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable production.
Patent CN102762535A details a safer, high-yield route for ABDNAZ. Eliminate explosive hazards and achieve >99.5% purity for cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102167723A details a safer solid-phase synthesis for Carbetocin, offering cost reduction in peptide manufacturing and high-purity API intermediates for global supply chains.
Novel ionic liquid catalyzed method for high-purity thiazolidinedione derivatives. Green chemistry approach reducing costs and improving supply chain reliability for diabetes drug intermediates.
Advanced chiral induction process for bedaquiline intermediates. Enhances yield and purity for reliable pharmaceutical intermediates supplier partnerships.